Tumorigenesis is a multifactorial and complex process involving multiple oncogenes and resulting in cancerous cells with specific proliferation capabilities as well as particular sensitivity to any given cytotoxic agent. In other words, every cancer is unique and efficient therapy requires extensive knowledge of its characteristics.

Traditional diagnostic information (age, tumor localization and size, histology and immuno-histochemistry) provides oncologists with limited guidance to optimize treatment options.

Molecular diagnostics, based on knowledge of the pathways involved in cancer initiation and development, have now the potential to classify the disease, measure its degree of aggressiveness and indicate which drug should preferably been used. They may also be used during follow up to monitor the effectiveness of the treatment.

To establish each tumors’ molecular identity, Ipsogen direclty analyzes markers that sign genetic alterations at the origin of the disease, delivering unrivalled sensitivity and reliability.